Redhill Biopharma
(NASDAQ:RDHL)
0.82
0.0516[6.72%]
At close: Jun 24
0.801
-0.0190[-2.32%]
After Hours: 7:55PM EDT
Day High/Low0.76 - 0.88
52 Week High/Low0.62 - 11.18
Open / Close0.86 / 0.82
Float / Outstanding- / 53.3M
Vol / Avg.17.2M / 1.7M
Mkt Cap43.7M
P/E-
50d Avg. Price1.23
Div / Yield-
Payout Ratio-
EPS-0.5
Total Float-

Redhill Biopharma (NASDAQ:RDHL), Earnings Estimates, EPS, and Revenue

Redhill Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Jun 23

EPS

$-0.030

Quarterly Revenue

$18.2M

Annual Revenue (as of Dec 31)

$22.1M

Earnings Recap

 

Redhill Biopharma (NASDAQ:RDHL) reported its Q1 earnings results on Thursday, June 23, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Redhill Biopharma reported an EPS of $0.03.

Revenue was down $2.34 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.28 which was followed by a 12.72% increase in the share price the next day.

Here's a look at Redhill Biopharma's past performance:

 

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.33 -0.21 -0.12 -0.34
EPS Actual -0.05 -0.50 -0.06 -0.05
Revenue Estimate 24.08M 24.52M 25.02M 22.70M
Revenue Actual 22.07M 21.61M 21.50M 20.57M

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings History

Analyze the earnings history of Redhill Biopharma using advanced sorting and filters.

Date
time
Quarter
Prior EPS
Est EPS
Actual EPS
EPS Surprise
Prior Rev
Est Rev
Actual Rev
Rev Surprise
Get Alert
No Data

Redhill Biopharma Questions & Answers

Q
When is Redhill Biopharma (NASDAQ:RDHL) reporting earnings?
A

Redhill Biopharma (RDHL) is scheduled to report earnings on August 25, 2022. The last reported earnings were for reported on June 23, 2022 for Q1.

Q
What were the latest earnings per share (EPS) for Redhill Biopharma (NASDAQ:RDHL)?
A

The Actual EPS was $-0.06, which beat the estimate of $-0.58.

Q
What were Redhill Biopharma’s (NASDAQ:RDHL) revenues?
A

The Actual Revenue was $483K, which beat the estimate of $220K.

Browse earnings estimates, EPS, and revenue on all stocks.